Highly illustrated and conveniently templated for quick reference, Atlas of Liver Pathology, 4th Edition, is a useful Atlas and text for every practicing pathologist or trainee who assesses liver biopsy specimens. From cover to cover, it contains all the information needed to identify histologic features and correlate them with clinical findings, offering a clearer understanding of the clinical implications of the disease as it relates to treatment. More than 1,200 high-quality, full-color images and illustrations provide you with a complete visual guide to the vast majority of liver diseases and assist in the diagnoses of biopsy and resected liver specimens.
Provides clear, templated information for each disease: Major Morphologic Features; Special Stains; Differential Diagnoses; Clinical and Biologic Behavior; and Treatment and Prognosis.
Incorporates relevant data from ancillary techniques (immunohistochemistry, cytology, cytogenetics and molecular genetics), giving you the necessary tools required to master the latest breakthroughs in diagnostic technology.
Incorporates the latest diagnostic biomarkers and their utility in differential diagnoses, newly described variants, and new histologic entities.
Contains two new chapters on liver biopsy interpretation and autoimmune hepatitis.
Features concise, bulleted text and abundant tables that cover common as well as rare diseases, differential diagnoses, and more.
1. Introduction to Developmental, Familial, and Metabolic Diseases - p. 271 2. Neonatal Hepatitis - p. 271 3. Biliary Atresia - p. 274 4. Cystic Diseases of the Liver - p. 279 5. Caroli disease - p. 281 6. Biliary microhamartoma (von Meyenburg complex) - p. 283 7. Peribiliary hilar cysts - p. 285 8. Polycystic Disease - p. 286 9. Congenital hepatic fibrosis (juvenile/adult type) - p. 288 10. Adult polycystic liver disease (PCLD) without renal involvement - p. 290 11. Cystic Fibrosis (Mucoviscidosis) - p. 292 12. Disorders of Endoplasmic Reticulum - p. 295 13. Hereditary Hyperbilirubinemias - p. 300 14. Gilbert syndrome - p. 300 15. Dubin-Johnson syndrome - p. 301 16. Progressive familial intrahepatic cholestasis (PFIC type 1) (Byler syndrome) - p. 304 17. Progressive familial intrahepatic cholestasis (PFIC type 1 variant) (benign recurrent intrahepatic cholestasis [BRIC] type 1) - p. 305 18. Disorders of Amino Acid Metabolism - p. 306 19. Storage Disorders - p. 309 20. Mitochondrial Fatty Acid Oxidation Disorders - p. 317 21. Porphyrias - p. 318 22. Sickle Cell Anemia - p. 323 23. Other Developmental, Familial, and Metabolic Disorders That May Cause Liver Damage - p. 326 24. 11. Diseases of Hepatic Iron and Copper Metabolism - p. 331 25. 12. Neoplasms and Related Lesions - p. 347 26. Primary Benign Hepatic Neoplasms - p. 347 27. Mucinous cystic neoplasm - p. 357 28. Angiomyolipoma - p. 365 29. Mesenchymal hamartoma - p. 367 30. Lymphangioma - p. 369 31. Solitary fibrous tumor - p. 369 32. Teratoma - p. 370 33. Plexiform neurofibroma (nerve sheath tumor) - p. 371 34. Biliary papillomatosis - p. 372 35. Primary Malignant Hepatic Neoplasms - p. 372 36. Hepatocellular carcinoma - p. 372 37. Cholangiocarcinoma - p. 373 38. Cholangiocarcinoma - p. 393 39. Combined hepatocellular–cholangiocarcinoma - p. 402 40. Rare mesenchymal malignant tumors - p. 413 41. Yolk sac tumor - p. 416 42. Cystic mesothelioma, malignant variant - p. 416 43. Hematologic Diseases - p. 417 44. α-heavy chain disease - p. 428 45. Metastatic Neoplasms - p. 428 46. Tumor-Like Lesions - p. 432 47. Regenerative Cirrhotic Nodules - p. 441 48. 13. Transplantation - p. 445 49. Introduction to Liver Transplant Pathology - p. 445 50. Back-Table Assessment of Donor Liver and Immediate Postperfusion State - p. 447 51. Time Frame of Liver Allograft Pathology - p. 447 52. Preservation (Harvesting, Reperfusion) Injury - p. 448 53. Acute Graft Failure (Primary Graft Nonfunction) - p. 450 54. Rejection - p. 451 55. Posttransplant Complications - p. 462 56. Posttransplant Opportunistic Infections - p. 465 57. Posttransplant Lymphoproliferative Disorder (PTLD) (Ebv Related and Non–Ebv Related) - p. 470 58. Recurrent Disease - p. 472 59. Acquired (De Novo) Posttransplant Liver Diseases - p. 484 60. Hepatic Changes After Hematopoietic Stem Cell Transplant: Graft-Versus-Host Disease (GVHD) - p. 484 61. 14. Miscellaneous Systemic Diseases With Hepatic Involvement - p. 488 62. Part II. Liver Biopsy Evaluation: Morphology With Differential Diagnoses - p. 513 63. PART II. LIVER BIOPSY EVALUATION: MORPHOLOGY WITH DIFFERENTIAL DIAGNOSES - p. 515 64. Index - p. 602
Highly illustrated and conveniently templated for quick reference, Atlas of Liver Pathology, 4th Edition, is a useful Atlas and text for every practicing pathologist or trainee who assesses liver biopsy specimens. From cover to cover, it contains all the information needed to identify histologic features and correlate them with clinical findings, offering a clearer understanding of the clinical implications of the disease as it relates to treatment. More than 1,200 high-quality, full-color images and illustrations provide you with a complete visual guide to the vast majority of liver diseases and assist in the diagnoses of biopsy and resected liver specimens.
Provides clear, templated information for each disease: Major Morphologic Features; Special Stains; Differential Diagnoses; Clinical and Biologic Behavior; and Treatment and Prognosis.
Incorporates relevant data from ancillary techniques (immunohistochemistry, cytology, cytogenetics and molecular genetics), giving you the necessary tools required to master the latest breakthroughs in diagnostic technology.
Incorporates the latest diagnostic biomarkers and their utility in differential diagnoses, newly described variants, and new histologic entities.
Contains two new chapters on liver biopsy interpretation and autoimmune hepatitis.
Features concise, bulleted text and abundant tables that cover common as well as rare diseases, differential diagnoses, and more.
1. Introduction to Developmental, Familial, and Metabolic Diseases - p. 271 2. Neonatal Hepatitis - p. 271 3. Biliary Atresia - p. 274 4. Cystic Diseases of the Liver - p. 279 5. Caroli disease - p. 281 6. Biliary microhamartoma (von Meyenburg complex) - p. 283 7. Peribiliary hilar cysts - p. 285 8. Polycystic Disease - p. 286 9. Congenital hepatic fibrosis (juvenile/adult type) - p. 288 10. Adult polycystic liver disease (PCLD) without renal involvement - p. 290 11. Cystic Fibrosis (Mucoviscidosis) - p. 292 12. Disorders of Endoplasmic Reticulum - p. 295 13. Hereditary Hyperbilirubinemias - p. 300 14. Gilbert syndrome - p. 300 15. Dubin-Johnson syndrome - p. 301 16. Progressive familial intrahepatic cholestasis (PFIC type 1) (Byler syndrome) - p. 304 17. Progressive familial intrahepatic cholestasis (PFIC type 1 variant) (benign recurrent intrahepatic cholestasis [BRIC] type 1) - p. 305 18. Disorders of Amino Acid Metabolism - p. 306 19. Storage Disorders - p. 309 20. Mitochondrial Fatty Acid Oxidation Disorders - p. 317 21. Porphyrias - p. 318 22. Sickle Cell Anemia - p. 323 23. Other Developmental, Familial, and Metabolic Disorders That May Cause Liver Damage - p. 326 24. 11. Diseases of Hepatic Iron and Copper Metabolism - p. 331 25. 12. Neoplasms and Related Lesions - p. 347 26. Primary Benign Hepatic Neoplasms - p. 347 27. Mucinous cystic neoplasm - p. 357 28. Angiomyolipoma - p. 365 29. Mesenchymal hamartoma - p. 367 30. Lymphangioma - p. 369 31. Solitary fibrous tumor - p. 369 32. Teratoma - p. 370 33. Plexiform neurofibroma (nerve sheath tumor) - p. 371 34. Biliary papillomatosis - p. 372 35. Primary Malignant Hepatic Neoplasms - p. 372 36. Hepatocellular carcinoma - p. 372 37. Cholangiocarcinoma - p. 373 38. Cholangiocarcinoma - p. 393 39. Combined hepatocellular–cholangiocarcinoma - p. 402 40. Rare mesenchymal malignant tumors - p. 413 41. Yolk sac tumor - p. 416 42. Cystic mesothelioma, malignant variant - p. 416 43. Hematologic Diseases - p. 417 44. α-heavy chain disease - p. 428 45. Metastatic Neoplasms - p. 428 46. Tumor-Like Lesions - p. 432 47. Regenerative Cirrhotic Nodules - p. 441 48. 13. Transplantation - p. 445 49. Introduction to Liver Transplant Pathology - p. 445 50. Back-Table Assessment of Donor Liver and Immediate Postperfusion State - p. 447 51. Time Frame of Liver Allograft Pathology - p. 447 52. Preservation (Harvesting, Reperfusion) Injury - p. 448 53. Acute Graft Failure (Primary Graft Nonfunction) - p. 450 54. Rejection - p. 451 55. Posttransplant Complications - p. 462 56. Posttransplant Opportunistic Infections - p. 465 57. Posttransplant Lymphoproliferative Disorder (PTLD) (Ebv Related and Non–Ebv Related) - p. 470 58. Recurrent Disease - p. 472 59. Acquired (De Novo) Posttransplant Liver Diseases - p. 484 60. Hepatic Changes After Hematopoietic Stem Cell Transplant: Graft-Versus-Host Disease (GVHD) - p. 484 61. 14. Miscellaneous Systemic Diseases With Hepatic Involvement - p. 488 62. Part II. Liver Biopsy Evaluation: Morphology With Differential Diagnoses - p. 513 63. PART II. LIVER BIOPSY EVALUATION: MORPHOLOGY WITH DIFFERENTIAL DIAGNOSES - p. 515 64. Index - p. 602
